United States · FDA National Drug Code directory
Zoledronic Acid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54288-183_1e2ee6a1-6ba6-463c-a6e5-0826e9978bde
- Product NDC
- 54288-183
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- zoledronic acid
- Labeler
- BPI Labs LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250605
- Source listing expiry
- 20261231
Source-listed ingredients
- ZOLEDRONIC ACID — 4 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (54288-183-01) / 5 mL in 1 VIAL, GLASS · 54288-183-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →